Lipid Nanoparticles

Lipid nanoparticles with specific DODAP and DOPE ratios provide spleen-specific gene delivery, addressing the need for targeted gene expression in organs like the spleen for effective immunotherapy and gene therapy.

JP7589998B2Active Publication Date: 2024-11-26HOKKAIDO UNIVERSITY
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
JP2021526847
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-06-24
Filing Date
2020-06-17
Publication Date
2024-11-26
Estimated Expiration
2040-06-17

AI Technical Summary

Technical Problem

There is a lack of gene delivery carriers that can selectively target and achieve high gene expression in organs other than the liver, which is crucial for realizing systemically administered gene therapy, particularly in organs like the spleen that are important for immunotherapy and gene therapy.

Method used

Lipid nanoparticles composed of specific ratios of 1,2-dioleoyl-3-dimethylaminopropane (DODAP) and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) are developed, with optional inclusion of sterols and polyalkylene glycol-modified lipids, to enhance spleen-specific gene expression.

Benefits of technology

The lipid nanoparticles exhibit high gene expression activity in the spleen, making them effective carriers for immunotherapy and gene therapy by selectively delivering genes to spleen cells.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007589998000014
    Figure 0007589998000014
  • Figure 0007589998000015
    Figure 0007589998000015
  • Figure 0007589998000016
    Figure 0007589998000016
Patent Text Reader

Abstract

This lipid nanoparticle serving as a gene delivery carrier capable of performing selective delivery to spleen contains DODAP (1,2-dioleoyl-3-dimethylaminopropane) and DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine). The ratio of DODAP content to the total content of DODAP and DOPE is 10-75 mol%, and the ratio of the total content of DODAP and DOPE to the total amount of lipid constituting the lipid nanoparticle is 60-88 mol%.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Agent for imparting ph dependant cationic property to lipid membrane structure, the lipid membrane structure given the ph dependant cationic property thereby, and production method for lipid membrane structure

    JP2013245190A

  • Lipid nanoparticle compositions and methods for mRNA delivery

    JP2014523411A

  • Lipid constructs for targeting to vascular smooth muscle tissue

    US5660855A

  • Lipid membrane structure for delivery into sirna cell

    WO2018230710A1